- Home
- FSHP vs ASRT Comparison
FSHP vs ASRT Comparison
Compare FSHP & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- ASRT
- Stock Information
- Founded
- FSHP 2018
- ASRT 1995
- Country
- FSHP United States
- ASRT United States
- Employees
- FSHP N/A
- ASRT N/A
- Industry
- FSHP
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- ASRT Health Care
- Exchange
- FSHP NYSE
- ASRT Nasdaq
- Market Cap
- FSHP 90.7M
- ASRT 78.3M
- IPO Year
- FSHP 2024
- ASRT 1997
- Fundamental
- Price
- FSHP $10.30
- ASRT $0.77
- Analyst Decision
- FSHP
- ASRT Strong Buy
- Analyst Count
- FSHP 0
- ASRT 4
- Target Price
- FSHP N/A
- ASRT $3.19
- AVG Volume (30 Days)
- FSHP 3.8K
- ASRT 332.9K
- Earning Date
- FSHP 01-01-0001
- ASRT 05-05-2025
- Dividend Yield
- FSHP N/A
- ASRT N/A
- EPS Growth
- FSHP N/A
- ASRT N/A
- EPS
- FSHP 0.17
- ASRT N/A
- Revenue
- FSHP N/A
- ASRT $125,763,000.00
- Revenue This Year
- FSHP N/A
- ASRT N/A
- Revenue Next Year
- FSHP N/A
- ASRT $1.84
- P/E Ratio
- FSHP $62.30
- ASRT N/A
- Revenue Growth
- FSHP N/A
- ASRT N/A
- 52 Week Low
- FSHP $9.99
- ASRT $0.73
- 52 Week High
- FSHP $10.30
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- ASRT 43.02
- Support Level
- FSHP N/A
- ASRT $0.74
- Resistance Level
- FSHP N/A
- ASRT $0.83
- Average True Range (ATR)
- FSHP 0.00
- ASRT 0.03
- MACD
- FSHP 0.00
- ASRT -0.00
- Stochastic Oscillator
- FSHP 0.00
- ASRT 36.67
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.